Performance Assessment of Sysmex DI-60: Is Digital Morphology Analyzer Reliable for White Blood Cell Differentials in Body Fluids?

被引:1
|
作者
Shin, Eunju [1 ]
Hur, Mina [1 ]
Kim, Hanah [1 ]
Lee, Gun-Hyuk [1 ]
Hong, Mi-Hyun [1 ]
Nam, Minjeong [2 ]
Lee, Seungho [3 ]
机构
[1] Konkuk Univ, Dept Lab Med, Sch Med, Seoul 05030, South Korea
[2] Korea Univ, Anam Hosp, Dept Lab Med, Seoul 02841, South Korea
[3] Dong A Univ, Coll Med, Dept Prevent Med, Busan 49315, South Korea
关键词
digital morphology analyzer; DI-60; body fluid; white blood cell differential; performance; turnaround time; IMAGE-ANALYSIS; MODE; RISK;
D O I
10.3390/diagnostics14060592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Few studies have evaluated digital morphology (DM) analyzers on body fluids (BF). We evaluated the performance of a DM analyzer, Sysmex DI-60 (Sysmex, Kobe, Japan) for white blood cell (WBC) differentials in BF samples. Methods: In five BF samples (two pleural fluids and three ascites) containing a single, dominant cell type (>80%, neutrophils, lymphocytes, macrophages, abnormal lymphocytes, and malignant cells in each sample), we evaluated the precision of the DI-60 and compared the WBC differentials and turnaround times (TAT) between DI-60 and manual counting. Results: The precision of the DI-60 pre-classification and verification was excellent (%CV, 0.01-3.16%). After verification, the DI-60 showed high sensitivity, specificity, and efficiency (ranges: 90.8-98.1%, 96.8-97.9%, and 92.5-98.0%, respectively) for the dominant cell types in neutrophil- and lymphocyte-dominant samples. For all samples, the DI-60 and manual counting showed high correlations for major cell types (neutrophils, lymphocytes, macrophages, and others, r = 0.72 to 0.94) after verification. The agreement between the pre-classification and verification of the DI-60 was strong in the neutrophil-dominant sample (kappa = 0.81). The DI-60 showed a significantly longer TAT (min: s) than manual counting for all samples (median TAT/slide: 6:28 vs. 1:53, p < 0.0001), with remarkable differences in abnormal lymphocyte- and malignant cell-dominant samples (21:05 vs. 2:06; 12:34 vs. 2:25). Conclusions: The DI-60 may provide reliable data in neutrophil- and lymphocyte-dominant BF samples. However, it may require longer times and higher workloads for WBC differentials especially in BF samples containing atypical cells. Further improvement would be needed before applying DM analyzers for routine clinical practice in BF analysis.
引用
收藏
页数:15
相关论文
共 36 条
  • [31] The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology
    Ruzicka, K
    Veitl, M
    Thalhammer-Scherrer, R
    Schwarzinger, I
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (03) : 391 - 396
  • [32] Cell counting chamber vs. Sysmex XN-1000 for determining white blood cell count and differentiation for body fluids
    Evren, Ebru
    Us, Ebru
    Hekimoglu, Can Huseyin
    Karahan, Zeynep Ceren
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (01): : 19 - 25
  • [33] Determining White Blood Cell Count In Sterile Body Fluids: Cell Counting Chamber vs Sysmex UF-1000i
    Evren, Ebru
    Us, Ebru
    Karahan, Zeynep Ceren
    GAZI MEDICAL JOURNAL, 2020, 31 (01): : 19 - 21
  • [34] Comparing Human-Level and Machine Learning Model Performance in White Blood Cell Morphology Assessment
    Lawrence, Patrick
    Brown, Christina
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 115 - 119
  • [35] Artificial intelligence and the blood film: Performance of the MC-80 digital morphology analyzer in samples with neoplastic and reactive cell types
    Zini, Gina
    Mancini, Francesca
    Rossi, Elena
    Landucci, Stefania
    d'Onofrio, Giuseppe
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (06) : 881 - 889
  • [36] Multi-site verification and performance of body fluids in-between Horiba Medical Yumizen h2500 with Sysmex XN-10 automated hematology analyzers and manual microscopy for morphology assessment
    Hege, M. L.
    CLINICAL CHEMISTRY, 2024, 70 : I59 - I59